Recombinant Human IL-24 Suppresses Lung Carcinoma Cell Growth via Induction of Cell Apoptosis and Inhibition of Tumor Angiogenesis
Authors:
- 1 June 2008
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 23 (3) , 310-320
Abstract
Previous studies have shown that interleukin-24 (IL-24; mda-7) as a novel tumor suppressor gene has tumor-suppressive activity against a broad spectrum of human cancers. However, the therapeutic effect of the recombinant human IL-24 (rhIL-24) protein purified from prokaryotic cells on human lung cancers has not been reported. In this study, we cloned the human gene coding for IL-24 from lipopolysaccharide-activated human peripheral blood mononuclear cells (PBMCs) by reverse-transcriptase polymerase chain reaction and constructed an expression vector pBV220-IL-24. We then transfected Escherichia coli DH5α with pBV220-IL-24. The soluble rhIL-24 was obtained from purified insoluble inclusion bodies of transfected cells by a denaturing and renaturing process. We demonstrated that the purified soluble rhIL-24 protein with 18.5 κDa was capable of (1) inducing in vitro apoptosis of A549 lung carcinoma cells; (2) activating PBMCs to secrete cytokines such as IL-6, tumor necrosis factor-α, and interferon-γ; (3) inhibiting the formation of blood capillaries on chicken embryonic allantois and in vivo tumor angiogenesis; and (4) inhibiting A549 lung tumor cell growth in vitro and in vivo. Therefore, our results indicate its potent suppressive effect on human lung carcinoma cell line and warrant its further investigation for therapeutic application against human lung cancer.Keywords
This publication has 34 references indexed in Scilit:
- Adenovirus-Mediated Il-24 Expression Suppresses Hepatocellular Carcinoma Growth via Induction of Cell Apoptosis and Cycling Arrest and Reduction of AngiogenesisCancer Biotherapy and Radiopharmaceuticals, 2007
- Soluble Human MDA-7/IL-24: Characterization of the Molecular Form(s) Inhibiting Tumor Growth and Stimulating MonocytesJournal of Interferon & Cytokine Research, 2006
- Combinatorial treatment of non‐small‐cell lung cancers with gefitinib and Ad.mda‐7 enhances apoptosis‐induction and reverses resistance to a single therapyJournal of Cellular Physiology, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Adenoviral-mediated mda-7 expression suppresses DNA repair capacity and radiosensitizes non-small-cell lung cancer cellsOncogene, 2004
- The Tumor Suppressor Activity of MDA-7/IL-24 Is Mediated by Intracellular Protein Expression in NSCLC CellsMolecular Therapy, 2004
- MDA-7 negatively regulates the β-catenin and PI3K signaling pathways in breast and lung tumor cellsMolecular Therapy, 2003
- Adenovirus-Mediated Gene Expression Radiosensitizes Non-Small Cell Lung Cancer Cells via -Independent MechanismsMolecular Therapy, 2002
- Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomasInternational Journal of Cancer, 2001
- Pingyangmycin as a 99mTc carrier in tumor localizationNuclear Medicine and Biology, 1995